Keng Leong Fung - 18 Mar 2026 Form 3 Insider Report for Basel Medical Group Ltd (BMGL)

Reporting relationship: Director
Issuer ticker: BMGL
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 14 Apr 2026, 10:18:51 UTC
Source filing: View source filing
Reporting owner signature: /s/ Keng Leong Fung

Key filing fact

Keng Leong Fung filed Form 3 for Basel Medical Group Ltd (BMGL) on 14 Apr 2026.

Key facts

This page summarizes Keng Leong Fung's Form 3 filing for Basel Medical Group Ltd (BMGL).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 14 Apr 2026, 10:18.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002127356 Primary reporting owner

Fung Keng Leong

Relationship: Director
Address: 6 NAPIER ROAD,, UNIT #02-10/11 GLENEAGLES MEDICAL CENTRE, SINGAPORE, SINGAPORE
Signature: /s/ Keng Leong Fung
Signature date: 14 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BMGL holding

Ordinary shares with no par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 10,205,229
Date: 18 Mar 2026
Ownership: See footnote
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Rainforest Capital VCC is a variable capital company incorporated in Singapore and holds 10,028,560 ordinary shares, 23,256 ordinary shares, 46,512 ordinary shares, and 106,901 ordinary shares of Basel Medical Group Ltd (the "Issuer") on behalf of Rainforest Capital VCC's four subfunds, Basel Medical Fund, Fan Mingchun, Wei Hua and Baselcorp Capital respectively. Keng Leong Fung (Raymond) is an ultimate beneficial owner of Basel Medical Fund and may be deemed to beneficially own the shares that Rainforest Capital VCC holds in the Issuer. Keng Leong Fung (Raymond) is also a director of the Issuer. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.